Prevalence of induced mania in patients treated with milnacipran: A comparison with paroxetine

European Psychiatry

Volumn 19, Issue 5, 2004, Pages 315-316

  Morishita, Shigeru ^a,b   Arita, Seizaburo ^b  

^a Kyoto Jujo Rehabilitation Hospital   (Japan)

^b KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Antidepressant therapy; Depression; Manic switch; Milnacipran; Paroxetine

Indexed keywords

MILNACIPRAN; PAROXETINE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DEPRESSION; FEMALE; HUMAN; HYPOMANIA; MAJOR CLINICAL STUDY; MALE; MANIA; PREVALENCE; PRIORITY JOURNAL; RATING SCALE; STUDENT T TEST;

ADULT; AGED; BIPOLAR DISORDER; COHORT STUDIES; CYCLOPROPANES; DEPRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; PAROXETINE; PREVALENCE; QUESTIONNAIRES; RETROSPECTIVE STUDIES; SEROTONIN UPTAKE INHIBITORS;

EID: 3342995273     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eurpsy.2004.05.005     Document Type: Article

References (6)

1. Bunney W.E. Jr. Psychopharmacology. 1978;Raven Press, New York
2. Endo S., Miura S., Murasaki M., et al. Clinical evaluation of milnacipran hydrochloride, a new antidepressant for depression and depressive state. Clin Eval. 23:1995;39-64. [in Japanese]
3. Lecrubier Y., Pletan Y., Solles A., Tournoux A., Magne V. Clinical efficacy of milnacipran: placebo-controlled trials. Int Clin Psychopharmacol. 11:(Suppl 4):1996;29-33
4. Matsubara R., Onodera I., Ito K., Okada F., Asano Y. Clinical evaluation of milnacipran hydrochloride (TN-912) on depression and depressive states. Rinshoiyaku. 11:1995;819-842. [in Japanese]
5. Preda A., MacLean R.W., Mazure C.M., Bowers M.B. Antidepressant- associated mania and psychosis resulting in psychiatric admission. J Clin Psychiatry. 62:2001;30-33
6. Serre C., Clerc G., Escande M., et al. An early clinical trial of milnacipran, a potential fourth generation antidepressant. Curr Ther Res Clin Exp. 39:1986;156-164